118 related articles for article (PubMed ID: 18507006)
1. Identification of potential chemoresistance genes in osteosarcoma.
Walters DK; Steinmann P; Langsam B; Schmutz S; Born W; Fuchs B
Anticancer Res; 2008; 28(2A):673-9. PubMed ID: 18507006
[TBL] [Abstract][Full Text] [Related]
2. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
Bruheim S; Xi Y; Ju J; Fodstad O
Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel genes involved in the synergistic antitumor effect of caffeine in osteosarcoma cells using cDNA macroarray.
Ii S; Ueda Y; Shimazaki M; Katsuta S; Takazawa K; Kanazawa Y; Tomita K; Tsuchiya H
Anticancer Res; 2008; 28(2A):645-53. PubMed ID: 18507003
[TBL] [Abstract][Full Text] [Related]
5. Expression of major vault protein gene in osteosarcoma patients.
Dalla-Torre CA; de Toledo SR; Yoshimoto M; Petrilli AS; Andrade JA; Chilton-MacNeill S; Squire JA; Zielenska M
J Orthop Res; 2007 Jul; 25(7):958-63. PubMed ID: 17415755
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.
Staege MS; Banning-Eichenseer U; Weissflog G; Volkmer I; Burdach S; Richter G; Mauz-Körholz C; Föll J; Körholz D
Exp Hematol; 2008 Jul; 36(7):886-96. PubMed ID: 18400362
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.
Yang C; Yang S; Wood KB; Hornicek FJ; Schwab JH; Fondren G; Mankin H; Duan Z
Apoptosis; 2009 Jan; 14(1):124-33. PubMed ID: 19052873
[TBL] [Abstract][Full Text] [Related]
8. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene.
Zucchini C; Bianchini M; Valvassori L; Perdichizzi S; Benini S; Manara MC; Solmi R; Strippoli P; Picci P; Carinci P; Scotlandi K
Bone; 2004 Apr; 34(4):672-9. PubMed ID: 15050898
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
11. Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma.
Hingorani P; Zhang W; Piperdi S; Pressman L; Lin J; Gorlick R; Kolb EA
Cancer Chemother Pharmacol; 2009 Sep; 64(4):733-40. PubMed ID: 19224214
[TBL] [Abstract][Full Text] [Related]
12. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
[TBL] [Abstract][Full Text] [Related]
13. In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential.
Tome Y; Tsuchiya H; Hayashi K; Yamauchi K; Sugimoto N; Kanaya F; Tomita K; Hoffman RM
J Cell Biochem; 2009 Oct; 108(2):362-7. PubMed ID: 19623575
[TBL] [Abstract][Full Text] [Related]
14. Altered morphology, nuclear stability and adhesion of highly metastatic derivatives of osteoblast-like SAOS-2 osteosarcoma cells.
Muff R; Nigg N; Gruber P; Walters D; Born W; Fuchs B
Anticancer Res; 2007; 27(6B):3973-9. PubMed ID: 18225558
[TBL] [Abstract][Full Text] [Related]
15. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases.
Zou CY; Wang J; Shen JN; Huang G; Jin S; Yin JQ; Guo QC; Li HM; Luo L; Zhang M; Zhang LJ
Acta Pharmacol Sin; 2008 Mar; 29(3):325-32. PubMed ID: 18298897
[TBL] [Abstract][Full Text] [Related]
17. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
Huang Z; Huang Y; He H; Ni J
Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
[TBL] [Abstract][Full Text] [Related]
18. HMGB1 promotes drug resistance in osteosarcoma.
Huang J; Ni J; Liu K; Yu Y; Xie M; Kang R; Vernon P; Cao L; Tang D
Cancer Res; 2012 Jan; 72(1):230-8. PubMed ID: 22102692
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy resistance in osteosarcoma: current challenges and future directions.
Chou AJ; Gorlick R
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1075-85. PubMed ID: 16831079
[TBL] [Abstract][Full Text] [Related]
20. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
